Clinical impact of blood cultures contaminated with coagulase-negative staphylococci at an academic medical center

Infection Control and Hospital Epidemiology

Volumn 32, Issue 6, 2011, Pages 623-625

  van der Heijden, Yuri F ^a   Miller, Geraldine ^a   Wright, Patty W ^a   Shepherd, Bryan E ^a   Daniels, Titus L ^a   Talbot, Thomas R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

ADULT; ARTICLE; BACTERIUM CONTAMINATION; BLOOD CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG BLOOD LEVEL; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; STAPHYLOCOCCUS INFECTION; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD SPECIMEN COLLECTION; COAGULASE; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; UNNECESSARY PROCEDURES;

EID: 79957951651     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/660096     Document Type: Article

References (10)

1. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997;24(4):584-602.
2. Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization: the true consequences of false-positive results. JAMA 1991;265(3):365-369.
3. Waltzman ML, Harper M. Financial and clinical impact of false-positive blood culture results. Clin Infect Dis 2001;33(3):296-299.
4. Segal GS, Chamberlain JM. Resource utilization and contaminated blood cultures in children at risk for occult bacteremia. Arch Pediatr Adolesc Med 2000;154(5):469-473.
5. Souvenir D, Anderson DE, Palpant S, et al. Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseu-dobacteremia, and therapy of patients. J Clin Microbiol 1998; 36(7):1923-1926.
6. Gander RM, Byrd L, DeCrescenzo M, Hirany S, Bowen M, Baughman J. Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department. J Clin Microbiol 2009;47(4):1021-1024.
7. Schifman RB, Strand CL, Meier FA, Howanitz PJ. Blood culture contamination: a College of American Pathologists Q-Probes study involving 640 institutions and 497,134 specimens from adult patients. Arch Pathol Lab Med 1998;122(3):216-221.
8. Surdulescu S, Utamsingh D, Shekar R. Phlebotomy teams reduce blood-culture contamination rate and save money. Clin Perform Qual Health Care 1998;6(2):60-62.
9. Weinbaum FI, Lavie S, Danek M, Sixsmith D, Heinrich GF, Mills SS. Doing it right the first time: quality improvement and the contaminant blood culture. J Clin Microbiol 1997;35(3):563-565.
10. Bekeris LG, Tworek JA, Walsh MK, Valenstein PN. Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions. Arch Pathol Lab Med 2005; 129(10):1222-1225.